XML 20 R6.htm IDEA: XBRL DOCUMENT v2.3.0.15
Basis of presentation
9 Months Ended
Sep. 30, 2011
Basis of presentation [Abstract] 
Basis of presentation
 
Note 1 –    Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information.  The consolidated balance sheet at December 31, 2010 has been derived from the audited balance sheet at that date; however, the accompanying financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.  The results of operations for the interim periods shown in this report are not necessarily indicative of expected results for any future interim period or for the entire fiscal year.  We believe that the quarterly information presented includes all adjustments (consisting of normal, recurring adjustments) necessary for a fair presentation in accordance with accounting principles generally accepted in the United States.  The accompanying condensed consolidated financial statements and notes should be read in conjunction with our Form 10-K for the year ended December 31, 2010.
 
Correction of Immaterial Error
 
This Form 10-Q reflects a correction of an immaterial error in our Consolidated Balance Sheet as of December 31, 2010, our Consolidated Statement of Cash Flows for the year ended December 31, 2010 contained in our Form 10-K for the fiscal year ended December 31, 2010 filed on March 9, 2011, and our Consolidated Statement of Cash Flows for the nine months ended September 30, 2010 contained in our Form 10-Q for the nine months ended September 30, 2010 filed on November 5, 2010.
 
The effect of this correction on the Consolidated Balance Sheet as of December 31, 2010 is summarized in the following table:
 
   
As of December 31, 2010
 
   
Previously
Reported
  
Adjustments
  
As Restated
 
Assets:
         
    Cash and cash equivalents
 $77,102,618  $(22,003,299) $55,099,319 
    Short-term investments
  12,013,707   22,003,299   34,017,006 
        Total cash, cash equivalents and short-term investments
 $89,116,325  $-  $89,116,325 
              
 
         The effects of this correction on the Consolidated Statement of Cash Flow for the year ended December 31, 2010 are summarized in the following table:
 
   
For the Year Ended December 31, 2010
 
 
   
Previously
       
   
Reported
  
Adjustments
  
As Restated
 
Cash Flows used in operating activities:
         
Amortization of investments
 $-  $348,061  $348,061 
Changes in assets and liabilities - Other Current Assets
  1,333,033   (92,142)  1,240,891 
Other cash flows used in operating activity items
  (5,792,939)  -   (5,792,939)
Net cash used in operating activities
 $(4,459,906) $255,919  $(4,203,987)
              
Cash Flows used in investing activities:
            
Purchases of property and equipment
 $(3,840,846) $-  $(3,840,846)
Purchases of marketable securities
  (12,032,241)  -   (12,032,241)
Purchases of short-term investments
  (12,013,707)  (22,259,218)  (34,272,925)
Proceeds from sale of marketable securities
  2,125,000   -   2,125,000 
Proceeds from sale of short-term investments
  25,000,000   -   25,000,000 
Net cash used in investing activities
 $(761,794) $(22,259,218) $(23,021,012)
              
Net cash from financing activities
 $267,323  $-  $267,323 
              
Effects of exchange rates on cash and cash equivalents
 $108,513   -  $108,513 
              
Net decrease in cash and cash equivalents
 $(4,845,864) $(22,003,299) $(26,849,163)
Cash and cash equivalents, beginning of the period
 $81,948,482      $81,948,482 
Cash and cash equivalents, end of the period
 $77,102,618  $(22,003,299) $55,099,319 
              
 
         The effects of this correction on the Consolidated Statement of Cash Flow for the nine months ended September 30, 2010 are summarized in the following table:
 
   
For the Nine Months Ended September 30, 2010
 
 
   
Previously
       
   
Reported
  
Adjustments
  
As Restated
 
Cash Flows used in operating activities:
         
Amortization of investments
 $-  $97,212  $97,212 
Changes in assets and liabilities - Other Current Assets
  402,125   (352,239)  49,886 
Other cash flows used in operating activity items
  (5,119,448)  -   (5,119,448)
Net cash used in operating activities
 $(4,717,323) $(255,027) $(4,972,350)
              
Cash Flows used in investing activities:
            
Purchases of property and equipment
 $(3,592,144) $-  $(3,592,144)
Purchases of short-term investments, marketable securities and other investments
  (24,055,638)  (22,259,218)  (46,314,856)
Proceeds from sale of short-term investments, marketable securities and other investments
  26,850,000   -   26,850,000 
Net cash used in investing activities
 $(797,782) $(22,259,218) $(23,057,000)
              
Net cash from financing activities
 $95,145  $-  $95,145 
              
Effects of exchange rates on cash and cash equivalents
 $95,163   -  $95,163 
              
Net decrease in cash and cash equivalents
 $(5,324,797) $(22,514,245) $(27,839,042)
Cash and cash equivalents, beginning of the period
 $81,948,482      $81,948,482 
Cash and cash equivalents, end of the period
 $76,623,685  $(22,514,245) $54,109,440 
              
 
         This correction to the 2010 presentation of approximately $22.0 million reflects the change in classification of a U.S. Treasury note with a maturity date of May 31, 2011 from cash and cash equivalents to short-term investments.  This $22.0 million U.S. Treasury note could have been sold without penalty at any time during the applicable period and the correction would have had no effect on our liquidity position during the period indicated.
 
     There have been no recent accounting pronouncements or changes in accounting pronouncements during the three and nine months ended September 30, 2011, as compared to the recent accounting pronouncements described in the Company’s Form 10-K, that are of significance, or potential significance to the Company.